Swiss Life Asset Management Ltd Purchases 11,129 Shares of Danaher Corporation $DHR

Swiss Life Asset Management Ltd boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 12.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 102,919 shares of the conglomerate’s stock after acquiring an additional 11,129 shares during the period. Swiss Life Asset Management Ltd’s holdings in Danaher were worth $20,405,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of the business. JPL Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at about $25,000. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher during the 3rd quarter worth approximately $27,000. Howard Hughes Medical Institute acquired a new stake in Danaher during the 2nd quarter worth approximately $27,000. Finally, TruNorth Capital Management LLC bought a new position in Danaher in the third quarter valued at approximately $28,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on DHR shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. TD Cowen reissued a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Morgan Stanley started coverage on Danaher in a report on Monday, December 1st. They issued an “overweight” rating and a $270.00 price target on the stock. Evercore reiterated an “outperform” rating and set a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Finally, Wells Fargo & Company boosted their price objective on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $253.55.

Danaher Stock Performance

NYSE:DHR opened at $190.42 on Friday. The stock has a 50 day simple moving average of $215.31 and a 200 day simple moving average of $214.96. The stock has a market cap of $134.66 billion, a P/E ratio of 37.78, a PEG ratio of 2.60 and a beta of 0.93. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company had revenue of $6.84 billion during the quarter, compared to the consensus estimate of $6.79 billion. During the same quarter last year, the firm earned $2.14 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. Research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Insider Activity at Danaher

In other news, EVP Gregory M. Milosevich sold 1,320 shares of Danaher stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.